Physician profile
John K Sontich
NPI 1013058908
$3,586,988.07
in general payments reported to CMS, 2019-2025
16 companies · $370K in 2025
The $370K reported for 2025 was more than what 99% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $559K · 2020: $422K · 2021: $770K · 2022: $684K · 2023: $402K · 2024: $380K · 2025: $370K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $1.1M · Consulting Fee: $14K · Travel and Lodging: $5,626 · Food and Beverage: $2,131 · Education: $97.23.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $1,130,158.18 |
| Consulting Fee | $13,500.00 |
| Travel and Lodging | $5,626.20 |
| Food and Beverage | $2,131.46 |
| Education | $97.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,585,798.24 | 2019-2025 | Hoffmann, Variax, Gamma |
| Depuy Synthes Sales INC. | $553.21 | 2019-2025 | Na, Va-Lcp, Motoband |
| Osteocentric Technologies, INC. | $159.23 | 2024 | Osteocentric 4.0 X 130mm Locking Bone Screw Fastener St |
| Bone Support INC. | $104.22 | 2022 | |
| Integra Lifesciences Corporation | $71.38 | 2023-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Kerecis Limited | $61.48 | 2023-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Smith+Nephew, INC. | $58.45 | 2019 | |
| Solventum Corporation | $29.67 | 2024 | V.A.C. Veraflo, Prevena |
| My01 INC. | $25.97 | 2023 | My01 Continuous Compartmental Pressure Monitor |
| Nuvasive Specialized Orthopedics, INC. | $21.08 | 2021 | |
| Organogenesis INC. | $20.18 | 2025 | Puraply Wound Matrix |
| Arteriocyte Medical Systems, INC. | $19.80 | 2025 | Magellan |
| Ferring Pharmaceuticals INC. | $17.90 | 2025 | Euflexxa |
| Orthofix Medical, INC. | $16.18 | 2025 | Accelstim |
| Bioventus LLC | $16.07 | 2024 | Durolane |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $15.01 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Sontich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.